Protara Therapeutics, Inc. TARA
Set alert
2.41 USD -0.07 -2.82%
At close · Nov 2
2.41 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
2.38 Day range 2.52
2.28 52-week range 7.82
- YTD
- -54.78%
- 1 year
- -53.47%
- Open
- 2.50
- Prev close
- 2.48
- Mkt cap
- 142.42M
- Vol
- 588.57K
- Avg vol
- 974.10K
- EPS
- -1.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.38
- High
- 2.52
- Forward P/E
- -1.61
- Beta
- 1.79
- Short ratio
- 14.46
- Inst. own
- 51.11%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.22
- 200-d avg
- 2.74
- 1y target
- 26.40
5D chart
Signals (58)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 4:00 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 10 hours ago |
| MACD: Buy Signal | Nov 2, 3:45 PM | 10 hours ago |
| MACD: Sell Signal | Nov 2, 3:35 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 10 hours ago |
| MACD: Buy Signal | Nov 2, 2:50 PM | 11 hours ago |
| RSI: Oversold | Nov 2, 1:35 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 1:25 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 12:05 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 11:45 AM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 10:20 AM | 15 hours ago |
| SMA: Bearish | Nov 2, 10:15 AM | 15 hours ago |
| RSI: Overbought | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 3 days ago |
Newest 20 of 58.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 26.40 +995.4% upside
Now 2.41
- Target (low)
- 14.00
- Target (mean)
- 26.40
- Target (high)
- 50.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 4
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.54333 | -0.61 – -0.51 | -0.90 | +39.6% | 0 | 0.0% | 3 |
| Next quarter | -0.62 | -0.67 – -0.55 | -0.97 | +36.1% | 0 | 0.0% | 3 |
| Current year | -2.30 | -2.38 – -2.22 | -3.57 | +35.6% | 0 | 0.0% | 3 |
| Next year | -2.28 | -2.67 – -1.54 | -2.30 | +0.7% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | Guggenheim | Reiterated | Buy | Buy |
| Dec 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 10, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 8, 2021 | Oppenheimer | Maintained | — | Outperform |
| Jun 4, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 19, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Jul 29, 2020 | Guggenheim | Initiated | — | Buy |